Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114333253 | 11433325 | 3 | F | 201412 | 20160707 | 20150830 | 20160716 | EXP | CA-AMGEN-CANSL2015066442 | AMGEN | 76.00 | YR | E | F | Y | 0.00000 | 20160715 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114333253 | 11433325 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG/ML, Q6MO | U | 125320 | SOLUTION FOR INJECTION | ||||||||
| 114333253 | 11433325 | 2 | SS | PROLIA | DENOSUMAB | 1 | Subcutaneous | UNK, Q6MO | U | 1055509 | 125320 | SOLUTION FOR INJECTION | |||||||
| 114333253 | 11433325 | 3 | SS | PROLIA | DENOSUMAB | 1 | U | 125320 | SOLUTION FOR INJECTION | ||||||||||
| 114333253 | 11433325 | 4 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | UNK | 0 | |||||||||||
| 114333253 | 11433325 | 5 | C | VITAMINS | VITAMINS | 1 | UNK | 0 | |||||||||||
| 114333253 | 11433325 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, QD AT BREAKFAST | 0 | 81 | MG | QD | ||||||||
| 114333253 | 11433325 | 7 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, QD AT BREAKFAST | 0 | 75 | MG | QD | ||||||||
| 114333253 | 11433325 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 80 MG, QD | 0 | 80 | MG | QD | ||||||||
| 114333253 | 11433325 | 9 | C | PREVACID | LANSOPRAZOLE | 1 | 30 MG, QD 30 MINS BEFORE BREAKFAST | 0 | 30 | MG | QD | ||||||||
| 114333253 | 11433325 | 10 | C | PRO-BISOPROLOL | 2 | 5 MG, BID MORNING AND AFTERNOON | 0 | 5 | MG | BID | |||||||||
| 114333253 | 11433325 | 11 | C | RIVOTRIL | CLONAZEPAM | 1 | 0.5 MG, AS NECESSARY (TABLET 3X/DAY) | 0 | .5 | MG | TID | ||||||||
| 114333253 | 11433325 | 12 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0.075 MG, QD MORNING BEFORE BREAKFAST | 0 | .075 | MG | QD | ||||||||
| 114333253 | 11433325 | 13 | C | ARTANE | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | 2 MG, JOUR | 0 | 2 | MG | |||||||||
| 114333253 | 11433325 | 14 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | 3 TO 4X/DAY IF PAIN | 0 | GEL | ||||||||||
| 114333253 | 11433325 | 15 | C | HYDRODIURIL | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 | |||||||||||
| 114333253 | 11433325 | 16 | C | LOTEMAX | LOTEPREDNOL ETABONATE | 1 | 0.5 %, QID | 0 | .5 | PCT | QID | ||||||||
| 114333253 | 11433325 | 17 | C | CEPHALEXIN. | CEPHALEXIN | 1 | 500 MG, TID | 0 | 500 | MG | TID | ||||||||
| 114333253 | 11433325 | 18 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MG, QD 30 MINS BEFORE BEDTIME | 0 | 25 | MG | QD | ||||||||
| 114333253 | 11433325 | 19 | C | APO HYDRO | 2 | 12.5 MG, QD AT BREAKFAST | 0 | 12.5 | MG | QD | |||||||||
| 114333253 | 11433325 | 20 | C | JAMP VITAMIN D | 2 | 10000 IU, QWK | 0 | 10000 | IU | /wk | |||||||||
| 114333253 | 11433325 | 21 | C | RESTASIS | CYCLOSPORINE | 1 | 0.4 ML (39X0.4 ML) 0.05%, BID | 0 | .4 | ML | BID | ||||||||
| 114333253 | 11433325 | 22 | C | TRIHEXYPHENIDYL | TRIHEXYPHENIDYL | 1 | 2 MG, TID IF NEEDED AT NIGHT | 0 | 2 | MG | TID | ||||||||
| 114333253 | 11433325 | 23 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 300 MG, QID AFTER MEALSA ND AT BEDTIME | 0 | 300 | MG | QID | ||||||||
| 114333253 | 11433325 | 24 | C | SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S)) | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | UNK UNK, QD | 0 | QD | ||||||||||
| 114333253 | 11433325 | 25 | C | SYSTANE VITAMIN OMEGA 3 SUPPLEMENT | 2 | UNK UNK, BID AT BREAKFAST AND DINNER | 0 | BID | |||||||||||
| 114333253 | 11433325 | 26 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | 100 MUG, BID MORNING AND EVENING | 0 | 100 | UG | BID | ||||||||
| 114333253 | 11433325 | 27 | C | TYLENOL | ACETAMINOPHEN | 1 | 500 MG, AS NECESSARY | 0 | 500 | MG | |||||||||
| 114333253 | 11433325 | 28 | C | EZETROL | EZETIMIBE | 1 | 10 MG, QD, AT BEDTIME | 0 | 10 | MG | QD | ||||||||
| 114333253 | 11433325 | 29 | C | ACTONEL | RISEDRONATE SODIUM | 1 | 35 MG, QWK MINS BEFORE BREAKFAST | 0 | 35 | MG | /wk | ||||||||
| 114333253 | 11433325 | 30 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 114333253 | 11433325 | 31 | C | CELEBREX | CELECOXIB | 1 | 100 MG, BID | 0 | 100 | MG | BID | ||||||||
| 114333253 | 11433325 | 32 | C | NASACORT | TRIAMCINOLONE ACETONIDE | 1 | 55 MUG, BID | 0 | 55 | UG | BID | ||||||||
| 114333253 | 11433325 | 33 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | UNK UNK, BID | 0 | BID | ||||||||||
| 114333253 | 11433325 | 34 | C | MONOCOR | BISOPROLOL FUMARATE | 1 | 5 MG, BID | 0 | 5 | MG | BID | ||||||||
| 114333253 | 11433325 | 35 | C | BISOPROLOL | BISOPROLOL | 1 | 0 | ||||||||||||
| 114333253 | 11433325 | 36 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 114333253 | 11433325 | 37 | C | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114333253 | 11433325 | 1 | Osteoporosis postmenopausal |
| 114333253 | 11433325 | 2 | Kyphosis |
| 114333253 | 11433325 | 3 | Osteoarthritis |
| 114333253 | 11433325 | 14 | Pain |
| 114333253 | 11433325 | 19 | Polyuria |
| 114333253 | 11433325 | 21 | Cataract |
| 114333253 | 11433325 | 31 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114333253 | 11433325 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114333253 | 11433325 | Arthralgia | |
| 114333253 | 11433325 | Arthritis | |
| 114333253 | 11433325 | Back pain | |
| 114333253 | 11433325 | Cellulitis | |
| 114333253 | 11433325 | Erythema | |
| 114333253 | 11433325 | Fatigue | |
| 114333253 | 11433325 | Hot flush | |
| 114333253 | 11433325 | Hyperhidrosis | |
| 114333253 | 11433325 | Neck pain | |
| 114333253 | 11433325 | Pain | |
| 114333253 | 11433325 | Pain in extremity | |
| 114333253 | 11433325 | Pelvic pain | |
| 114333253 | 11433325 | Peripheral swelling | |
| 114333253 | 11433325 | Rash | |
| 114333253 | 11433325 | Renal failure | |
| 114333253 | 11433325 | Spinal pain | |
| 114333253 | 11433325 | Tooth disorder | |
| 114333253 | 11433325 | Wrist fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114333253 | 11433325 | 1 | 20141224 | 0 | ||
| 114333253 | 11433325 | 2 | 20150623 | 0 | ||
| 114333253 | 11433325 | 6 | 20150508 | 0 | ||
| 114333253 | 11433325 | 7 | 20150706 | 0 | ||
| 114333253 | 11433325 | 8 | 20150706 | 0 | ||
| 114333253 | 11433325 | 9 | 20150706 | 0 | ||
| 114333253 | 11433325 | 10 | 20150706 | 0 | ||
| 114333253 | 11433325 | 11 | 20150706 | 0 | ||
| 114333253 | 11433325 | 12 | 20150706 | 0 | ||
| 114333253 | 11433325 | 14 | 20150706 | 0 | ||
| 114333253 | 11433325 | 16 | 20150623 | 0 | ||
| 114333253 | 11433325 | 18 | 20150706 | 0 | ||
| 114333253 | 11433325 | 19 | 20150706 | 0 | ||
| 114333253 | 11433325 | 20 | 20150706 | 201601 | 0 | |
| 114333253 | 11433325 | 21 | 20150706 | 0 | ||
| 114333253 | 11433325 | 22 | 20150706 | 0 | ||
| 114333253 | 11433325 | 23 | 20150611 | 0 | ||
| 114333253 | 11433325 | 24 | 20150611 | 0 | ||
| 114333253 | 11433325 | 25 | 20150611 | 0 | ||
| 114333253 | 11433325 | 26 | 20150508 | 0 | ||
| 114333253 | 11433325 | 27 | 20150508 | 0 | ||
| 114333253 | 11433325 | 28 | 20141211 | 0 | ||
| 114333253 | 11433325 | 29 | 20141126 | 0 | ||
| 114333253 | 11433325 | 30 | 20141126 | 0 | ||
| 114333253 | 11433325 | 31 | 20131009 | 0 | ||
| 114333253 | 11433325 | 32 | 20130831 | 0 |